Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1939 2
1943 1
1946 5
1947 2
1948 4
1949 1
1950 3
1951 5
1952 4
1953 5
1954 4
1955 4
1956 5
1957 2
1958 3
1959 1
1960 3
1961 3
1962 4
1963 3
1964 4
1965 5
1966 9
1967 12
1968 2
1969 7
1970 16
1971 7
1972 12
1973 15
1974 8
1975 10
1976 10
1977 10
1978 12
1979 15
1980 18
1981 12
1982 16
1983 19
1984 21
1985 18
1986 21
1987 34
1988 42
1989 34
1990 43
1991 42
1992 36
1993 33
1994 45
1995 45
1996 41
1997 52
1998 58
1999 52
2000 53
2001 59
2002 48
2003 44
2004 49
2005 50
2006 72
2007 58
2008 73
2009 82
2010 87
2011 98
2012 109
2013 97
2014 138
2015 141
2016 125
2017 119
2018 130
2019 132
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

2,497 results
Results by year
Filters applied: . Clear all
Page 1
Schizophrenia risk from complex variation of complement component 4
Sekar A, et al. Nature 2016. Among authors: Rose SA. PMID 26814963 Free PMC article.
Schizophrenia's strongest genetic association at a population level involves variation in the major histocompatibility complex (MHC) locus, but the genes and molecular mechanisms accounting for this have been challenging to identify. ...
Schizophrenia's strongest genetic association at a population level involves variation in the major histocompatibility complex (MHC) …
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
van Vollenhoven RF, et al. Lancet 2018 - Clinical Trial. Among authors: Rose S. PMID 30249507
BACKGROUND: Ustekinumab is a monoclonal antibody targeting interleukin (IL)-12 and IL-23 and is approved for the treatment of plaque psoriasis, psoriatic arthritis, and Crohn's disease. ...
BACKGROUND: Ustekinumab is a monoclonal antibody targeting interleukin (IL)-12 and IL-23 and is approved for the treatment of plaque psorias …
2,497 results
Jump to page
Feedback